An Insurer's Care Transition Program Emphasizes Medication Reconciliation, Reduces Readmissions And Costs

Area of Science:

• Health Services Research
• Pharmacoeconomics
• Patient Safety

Background:

• Adverse drug events and medication adherence challenges drive hospital readmissions.
• Medication reconciliation's impact on readmissions and costs requires further real-world evidence.

Purpose of the Study:

• To evaluate an insurer-initiated, pharmacist-led care transition program.
• To assess the program's effect on medication use, readmissions, and cost-effectiveness in high-risk patients.

Main Methods:

• A voluntary, insurer-initiated program involving pharmacist-led home visits and telephone support.
• Focus on medication reconciliation for high-risk patients post-discharge.
• Analysis of readmission rates and program costs.

Main Results:

• Program participants experienced a 50% relative risk reduction in 30-day readmissions.
• An absolute risk reduction of 11.1% in readmissions was observed.
• The program yielded a return on investment of $2 saved for every $1 spent.

Conclusions:

• Pharmacist-led care transition programs, including medication reconciliation, improve clinical outcomes.
• These programs demonstrate significant potential for reducing total healthcare costs.
• Real-world evidence supports the value of insurer-initiated pharmacist interventions.